The European Union (EU) and France have committed a €10.2 million investment to strengthen Nigeria’s pharmaceutical manufacturing capacity, in what officials describe as a major step toward health sovereignty and industrial transformation.
The investment, announced under the Global Gateway’s Manufacturing and Access to Vaccines, Medicines and Health Technologies (MAV+) Initiative, will fund the Quality Uplift for Advancing Local Industry in Medicine Standards (Qualimeds Nigeria) project—a 44-month programme designed to modernise local production, improve medicine quality, and expand acces
Continue Reading on The Guardian Nigeria
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.